Table 2 Patients CMR characteristics
Characteristics | All patients | No appropriate ICD therapy | Appropriate ICD therapy | P-value |
|---|---|---|---|---|
(n = 68) | (n = 53) | (n = 15) | ||
LVDd (SAX), mm | 67.6 ± 6.7 | 67.3 ± 6.6 | 68.7 ± 7.4 | 0.45 |
LV length (4 chamber), mm | 97.8 ± 8.9 | 98.2 ± 9.5 | 96.1 ± 6.7 | 0.45 |
Sphericity index | 0.54 ± 0.08 | 0.52 ± 0.07 | 0.60 ± 0.08 | 0.001 |
Septal wall thickness, mm | 8.6 ± 2.6 | 8.4 ± 2.4 | 9.1 ± 3.1 | 0.39 |
Inferolateral wall thickness, mm | 7.4 ± 2.0 | 7.4 ± 1.9 | 7.5 ± 2.6 | 0.84 |
RWT_2P | 0.22 ± 0.06 | 0.22 ± 0.06 | 0.22 ± 0.08 | 0.99 |
RWT_AP | 0.24 ± 0.06 | 0.24 ± 0.06 | 0.24 ± 0.08 | 0.77 |
LV EDV, ml | 268.6 ± 80.3 | 261.6 ± 76.8 | 293.6 ± 89.9 | 0.17 |
LV EDVI, ml/m2 | 137.5 ± 36.0 | 134.0 ± 31.7 | 149.6 ± 47.5 | 0.14 |
LV ESV, ml | 192.5 ± 78.0 | 182.2 ± 71.9 | 228.9 ± 89.8 | 0.04 |
LV EF, % | 30.1 ± 9.4 | 31.8 ± 8.9 | 23.9 ± 8.7 | 0.003 |
LV mass, g | 155.3 ± 46.4 | 147.5 ± 40.3 | 182.7 ± 57.0 | 0.009 |
LV mass index, g/m2 | 80.1 ± 22.6 | 76.5 ± 19.5 | 92.6 ± 28.5 | 0.014 |
LV mass/LV EDV, g/ml | 0.59 ± 0.13 | 0.58 ± 0.13 | 0.63 ± 0.13 | 0.16 |
LV LGE, n (%) | 38 (56) | 27 (51) | 11 (73) | 0.11 |
LV LGE2SD, g | 26.9 ± 33.5 | 23.8 ± 31.9 | 38.0 ± 38.2 | 0.13 |
LV LGE4SD, g | 20.9 ± 29.1 | 19.1 ± 28.9 | 27.4 ± 30.1 | 0.18 |
LV LGE6SD, g | 16.2 ± 24.5 | 15.1 ± 24.7 | 20.2 ± 24.5 | 0.17 |
Heterogeneous LGE(2-4SD), g | 6.6 ± 9.8 | 5.5 ± 8.6 | 10.6 ± 12.8 | 0.09 |
Heterogeneous LGE(4-6SD), g | 4.7 ± 6.8 | 4.0 ± 6.0 | 7.1 ± 8.9 | 0.10 |
Heterogeneous LGE(2-6SD), g | 11.3 ± 15.3 | 9.5 ± 13.0 | 17.8 ± 20.8 | 0.12 |
RV EDV, ml | 156.6 ± 58.5 | 156.4 ± 59.6 | 157.3 ± 56.5 | 0.96 |
RV EDVI, ml/m2 | 77.9 ± 19.9 | 77.5 ± 18.3 | 79.2 ± 25.4 | 0.77 |
RV ESV, ml | 80.9 ± 42.0 | 77.5 ± 38.2 | 92.9 ± 53.0 | 0.21 |
RV EF, % | 48.9 ± 12.5 | 50.3 ± 12.0 | 43.8 ± 13.3 | 0.08 |
RV EFÂ <Â 40, n (%) | 17 (25) | 9 (17) | 8 (53) | 0.02 |